Despite a poor report from the Institute for Supply Management showing that the Purchasing Managers Index contracted in May to 49, from April's 50.7, the major indexes all closed...
Keep Reading →
June 4 - News
Editor's Note: The initial article refers to Abraxane's prostate cancer trials. That is incorrect, Abraxane has priority review for pancreatic cancer.
Keep Reading →
June 4 - News
Yesterday, Merck & Co., Inc. (NYSE:MRK) reported overwhelmingly positive interim results for its experimental melanoma drug lambrolizumab.
Keep Reading →
June 3 - News
Though it's had its share of ups and downs this morning, the Dow Jones Industrial Average has kept its feet firmly in positive territory.
Keep Reading →
June 3 - News
The Food and Drug Administration stays busy with approvals, recommendations, and reviews.
Keep Reading →
June 3 - News
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
Keep Reading →
June 3 - News
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
Keep Reading →
June 3 - News
Johnson & Johnson (NYSE:JNJ) may be involved in everything from hip implants to pharmaceuticals, but it's the latter that brings in the majority of the profits and fuels any...
Keep Reading →
May 31 - News
Pfizer Inc. (NYSE:PFE) recently announced plans to sell its remaining 80% stake in animal-health company Zoetis Inc (NYSE:ZTS) after about four months on the public market.
Keep Reading →
May 31 - News
We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more.
Keep Reading →
May 31 - News
Owners of Pfizer Inc. (NYSE:PFE) stock have an animal of a decision to make.
Keep Reading →
May 31 - News
You have plenty of choices of where to invest your portfolio.
Keep Reading →
May 31 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) was in 18 hedge funds' portfolio at the end of March. GSK investors should be aware of a decrease in enthusiasm from smart money lately.
Keep Reading →
May 29 - News
Tragedy has always inspired Americans to give their support to those in need.
Keep Reading →
May 29 - News
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Keep Reading →
May 29 - News
We've been speculating for almost a year that Amarin Corporation plc (ADR) (NASDAQ:AMRN) would be purchased by AstraZeneca plc (ADR) (NYSE:AZN).
Keep Reading →
May 29 - News
A recent review published online in the journal, The Lancet, found nearly a quarter of all adults are unhappy with their sleep patterns.
Keep Reading →
May 29 - News
Following the three-day holiday weekend, investors came back to work to find the stock market soaring, with the Dow Jones Industrials climbing more than 200 points by 10:45 a...
Keep Reading →
May 28 - News
If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology's annual meeting in Chicago...
Keep Reading →
May 28 - News
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 28 - News
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
May 24 - News
The company announced Tuesday after the close that it had set up an accelerated share repurchase agreement with Goldman Sachs Group, Inc.
Keep Reading →
May 24 - News
Merck & Co., Inc. (NYSE:MRK) was in 56 hedge funds' portfolio at the end of March. MRK investors should pay attention to a decrease in hedge fund sentiment of late.
Keep Reading →
May 23 - News
This morning, the Dow Jones Industrial Average moved as high as 155 points before starting its descent and ending the day down 80 points, or 0.52%.
Keep Reading →
May 23 - News
Drug companies have been revenue generating machines for long.
Keep Reading →
May 22 - News
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Keep Reading →
May 22 - News
There's hardly any certainty in the market, but even I have to admit it's become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight...
Keep Reading →
May 21 - News
Federal Reserve officials seem to be having a running internal debate about the efficacy and future of quantitative easing.
Keep Reading →
May 21 - News
We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay.
Keep Reading →
May 21 - News
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Keep Reading →
May 21 - News
This morning's movements in the Dow Jones Industrials look eerily familiar to those who have been watching the day-to-day movements of the average in recent months.
Keep Reading →
May 20 - News
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Keep Reading →
May 20 - News
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
Keep Reading →
May 20 - News
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Keep Reading →
May 20 - News
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Keep Reading →
May 20 - News
Nearly 400 former workers at Pfizer Inc.
Keep Reading →
May 17 - News
Although homebuilder confidence is rising in May, the number of housing starts in April fell to a five-month low.
Keep Reading →
May 16 - News
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has been on a solid run since early last year and it has continued to climb to new highs this year as well.
Keep Reading →
May 15 - News
Pfizer Inc. (NYSE:PFE) stock has been a boon for growth investors over the past year.
Keep Reading →
May 15 - News
Confirmation bias – one of the psychological traps investors can be most prone to falling victim to.
Keep Reading →
May 15 - News
Editor's Note: Related Tickers: Citigroup Inc. (NYSE:C), Hess Corp. (NYSE:HES), Yahoo! Inc.
Keep Reading →
May 15 - Hedge Funds
Pharmaceutical companies in the U.S. are not having it easy these days.
Keep Reading →
May 14 - News
Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher.
Keep Reading →
May 13 - News
Pfizer Inc. (NYSE:PFE) saw a strong pullback earlier this month, with its stock tumbling over 6% after reporting first-quarter earnings results.
Keep Reading →
May 13 - News
A study published in The New England Journal of Medicine testing omega-3 fatty acids -- commonly found in fish oil -- in patients with risk factors for cardiovascular disease ...
Keep Reading →
May 13 - News
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks.
Keep Reading →
May 13 - News
In the world of investing, the amount of data to factor into the purchase of a stock can be overwhelming.
Keep Reading →
May 12 - News
Only 19 drugs have ever netted at least $5 billion in annual sales -- and most were at their peak --according to a list compiled by Simon King of Forbes earlier this year.
Keep Reading →
May 9 - News
Recently, I have focused in on some companies that play a major role in diabetic's lives like mine.
Keep Reading →
May 8 - News
Synthetic biology company and industrial bio-enzyme manufacturer Codexis, Inc. (NASDAQ:CDXS) announced its first-quarter earnings after the market closed Tuesday.
Keep Reading →
May 8 - News
